Centro Hospitalar de São João, EPE

Porto 4200-319

1 studies enrolling now · 12 studies all time

What they study most

Advanced Cholangiocarcinoma, Brain Edema, Crohn's Disease, FGFR2 Gene Mutation, First Line Non-Small Cell Lung Cancer, Follicular Lymphoma, Hypoparathyroidism, Leber's Hereditary Optic Neuropathy (LHON), Refractory Metastatic Gastric Cancer, Small-cell Lung Cancer, Stroke, Acute, Ulcerative Colitis

Studies at this site

• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease — Recruiting now
• Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
• A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE) — Completed
• Study to Assess the Efficacy and Safety of Raxone in LHON Patients — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis — Completed
• Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer — Completed